The Saudi Arabia pharmaceutical market is estimated to be valued at US$ 5,209.5 Mn by 2016 end and is expected to expand at a CAGR of 9.0% over the forecast period (2016–2026). The significant rise in lifestyle-related diseases and the developments in healthcare infrastructure are expected to influence the demand fo.
JEDDAH: Saudi Arabian pharmaceutical firm Jamjoom Pharma has signed an agreement to invest over $52 million in Uzbekistan, as the firm continues its expansion into the Central Asian region, the company's vice chairman said. In an exclusive interaction with Arab News on the sidelines of the fourth meeting of the Saudi-Uzbeki Business Council in Jeddah, Mahmoud Jamjoom, vice
Kazakhstan accounts for 70% of Saudi total investment inflow to CA region – Tokayev en.trend.az - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from en.trend.az Daily Mail and Mail on Sunday newspapers.
Pharmerging Market, By Products (Pharmaceuticals, Healthcare and Others (IT and Record Management)), By Economy (Tier-1, Tier-2 and Tier-3), By Indication.
Saudi Arabia intends to invest about $8 billion in various economic sectors in Egypt, which will ease the Egyptian economy's wheels amid the global crisis.